We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16.5B
AUM Growth
+$861M
Cap. Flow
+$217M
Cap. Flow %
1.32%
Top 10 Hldgs %
30.08%
Holding
735
New
44
Increased
335
Reduced
212
Closed
49

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$60.1M
2
QCOM icon
Qualcomm
QCOM
+$53.4M
3
NU icon
Nu Holdings
NU
+$48.5M
4
AMZN icon
Amazon
AMZN
+$46.5M
5
BMA icon
Banco Macro
BMA
+$43.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.8M
2
ADBE icon
Adobe
ADBE
+$36.1M
3
VIPS icon
Vipshop
VIPS
+$33.1M
4
SBUX icon
Starbucks
SBUX
+$31.4M
5
LOW icon
Lowe's Companies
LOW
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Healthcare 27.47%
3 Financials 9.69%
4 Consumer Discretionary 7.72%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADI icon
226
Analog Devices
ADI
$181B
$13.1M 0.08%
57,354
-21,626
-27% -$4.61M
CAH icon
227
Cardinal Health
CAH
$53.7B
$12.9M 0.08%
131,585
-6,239
-5% -$636K
ALLY icon
228
Ally Financial
ALLY
$13.3B
– –
0
– –
TXN icon
229
Texas Instruments
TXN
$255B
$12.7M 0.08%
65,112
+3,932
+6% +$726K
BR icon
230
Broadridge
BR
$17.7B
$12.6M 0.08%
63,962
-28,795
-31% -$5.71M
WTRG icon
231
Essential Utilities
WTRG
$11.2B
$12.3M 0.07%
329,150
+43,048
+15% +$1.6M
ARQT icon
232
Arcutis Biotherapeutics
ARQT
$3.48B
$12.2M 0.07%
+1,307,481
New +$11.8M
HASI icon
233
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.91B
$12M 0.07%
406,614
-240,467
-37% -$7.03M
ACLX
234
DELISTED
Arcellx
ACLX
$12M 0.07%
217,008
-3,000
-1% -$163K
CLDX icon
235
Celldex Therapeutics
CLDX
$2.8B
$11.8M 0.07%
317,509
– –
WRK
236
DELISTED
WestRock Company
WRK
$11.7M 0.07%
233,171
+88,895
+62% +$4.49M
LEGN icon
237
Legend Biotech
LEGN
$3.73B
$11.6M 0.07%
261,035
+40,003
+18% +$1.85M
OLMA icon
238
Olema Pharmaceuticals
OLMA
$1.05B
$11.5M 0.07%
1,058,673
+705,655
+200% +$7.65M
LH icon
239
Labcorp
LH
$24.7B
$11.5M 0.07%
56,283
+2,558
+5% +$520K
C icon
240
Citigroup
C
$223B
$11.3M 0.07%
177,800
+13,851
+8% +$854K
VRNA
241
DELISTED
Verona Pharma
VRNA
$11.2M 0.07%
+772,997
New +$11.3M
RYTM icon
242
Rhythm Pharmaceuticals
RYTM
$7.28B
$11.1M 0.07%
+271,398
New +$10.8M
ITT icon
243
ITT
ITT
$17.7B
$11.1M 0.07%
85,910
– –
CAT icon
244
Caterpillar
CAT
$402B
$11M 0.07%
33,164
+66
+0.2% +$22.9K
SPG icon
245
Simon Property Group
SPG
$75.1B
$10.7M 0.07%
70,673
+49,806
+239% +$7.34M
VERA icon
246
Vera Therapeutics
VERA
$2.53B
$10.6M 0.06%
293,760
+185,760
+172% +$7.37M
IMCR icon
247
Immunocore
IMCR
$1.72B
$10.6M 0.06%
313,423
+124,417
+66% +$6.35M
AMRC icon
248
Ameresco
AMRC
$1.12B
$10.6M 0.06%
368,059
-169,968
-32% -$4.69M
GH icon
249
Guardant Health
GH
$19.3B
$10.6M 0.06%
366,145
-99,992
-21% -$2.33M
MLTX icon
250
MoonLake Immunotherapeutics
MLTX
$1.66B
$10.5M 0.06%
239,000
– –
8 9
10
11 12

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2024 Portfolio in Review

As of Q2 2024, Candriam SCA held 735 positions worth $16.5B, up 5.5% from $15.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q2 2024 filing shows 44 new, 335 increased, 212 reduced and 49 closed positions. Its largest new stake was Banco Macro: 754,200 shares worth $43.2M. The largest sale was Apple, an estimated $40.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2024 buy was Banco Macro: 754,200 shares worth $43.2M.
  • Candriam SCA added most to Eli Lilly in Q2 2024, an estimated $60.1M increase.
  • Candriam SCA's biggest Q2 2024 reduction was Apple, cutting an estimated $40.8M.
  • Candriam SCA fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $16.5M.
  • Candriam SCA's ten largest holdings make up 30% of its $16.5B portfolio in Q2 2024.
  • Candriam SCA opened 44 new positions and closed 49 in Q2 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $16.5B.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.